Low Fracture Risk Observed with IAD Treatment for Prostate Cancer
Men with nonmetastatic, hormone-sensitive prostate cancer experience the greatest average change in bone mineral density (BMD) during the early treatment period of intermittent androgen deprivation (IAD) and fractures are rare.